Clinical trial
Intravitreal Avastin Injection for the Treatment of Choroidal Neovascularization Secondary to Pattern Dystrophy
NCT00391144 is registered in ClinicalTrials.gov with University of Trieste as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intravitreal Avastin Injection for the Treatment of Choroidal Neovascularization Secondary to Pattern Dystrophy
- Lead sponsor
- University of Trieste
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- July 31, 2006
- Completion date
- October 31, 2006
- Enrollment
- 5
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
choroidal neovascularization secondary to pattern dystrophy